Rapid. Agile. Clean. Secure. Reactions in minutes instead of hours, capacity added one modular reactor at a time, less solvent and waste, and the same process from bench to production.
The United States has outsourced pharmaceutical manufacturing to a critical degree, creating supply chain fragility, economic waste, and national security risks.
Microwave chemistry is widely used in early drug development. But at scale, developers must abandon it and redevelop the process for conventional heat - adding years and significant cost per drug.
Years added per drugUS manufacturers produce only 3% of global API volume. More than 200 drugs are in active shortage. Conventional domestic manufacturing struggles to compete with offshore costs.
200+ drugs in shortageWhen supply chains break, the US has little domestic fallback. Conventional API plants take years and billions to build. Foreign-dependent supply chains put military and civilian pharmaceutical supply at risk.
Years to build a new plantMicrowave energy reaches only a centimeter or two into a reaction mixture. That limit has kept microwave chemistry at the flask for decades. Accelbeam's reactor architecture is built to deliver energy across the whole volume instead.
Unlike conventional heating that heats vessel walls and waits for conduction, Accelbeam's reactor delivers microwave energy directly to the entire reaction volume. Uniform power across the full volume, at scale.
Uniform heating keeps reaction conditions consistent as volume grows, so a process developed at the bench is designed to transfer to production volume. No process redevelopment required. Direct bench-to-commercial in the same technology.
Scale output by adding reactor stacks - not building bigger reactors or new plants. Enables distributed, rapid-response manufacturing.
What microwave chemistry delivers at the bench, and what Accelbeam's reactor is built to deliver at production scale.
Rapid, even heating can carry a reaction to completion before side reactions take over.
Less time at temperature means fewer by-products, and less purification downstream.
Chemistry that takes hours under conventional heat can finish in minutes.
Uniform heating is designed to keep the process the same from bench to production volume.
Less solvent and fewer purification cycles leave less to dispose of.
Energy goes into the reaction mixture, not into heating the vessel and the room around it.
Microwaves couple directly with polar molecules, heating the reactants instead of the vessel wall.
Sealed vessels hold solvents above their boiling point, opening faster reaction conditions.
Capacity grows two ways: larger reactors for volume, and identical units in parallel for resilience. Together they make the platform agile, resilient and fast to respond.
The same heating architecture at every size.
The same process at every volume.
One facility, many medicines.
Capacity with no single point of failure.
Capacity where and when it is needed.
Accelbeam works where the chemistry is already shown to respond to microwave heating, across active ingredients, intermediates and peptides.
| Metric | Traditional Batch | Accelbeam |
|---|---|---|
| Cycle Time | Long batch cycles | A fraction of the time |
| Solvent Use | High | Substantially lower |
| Heat Transfer | Surface-dependent | Volumetric / uniform |
| Development Tiers | Multiple pilot scales | Direct-to-commercial |
| Yield at Scale | Can drop from lab yield | Designed to maintain lab yield |
| Purification | A major share of cost | Fewer cycles needed |
| Facility Cost | New plant, multi-year build | Modular |